The results showed that in CD34+ cells isolated from CML patients at CP, BOR and PSI enhanced IM-caused inhibition of the CFU-total, BFU-E, and CFU-GEMM. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.